In our study, patients with PD-L1 expression had better DFS and OS than those without PD-L1 expression in stage I-II disease but not in stage III-IV disease, which was consistent with a previous study of ESCC (37). This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.